Sign Out
Click on icon to see table/diagram/imageAdverse reactions reported with the use of eye drops containing phosphate buffers: Cases of corneal calcification have been reported very rarely in association with the use of phosphate-containing eye drops in some patients with significantly damaged corneas.
Paediatric Population: In two short term clinical trials (≤12 weeks), involving 93 (25 and 68) paediatric patients the safety profile was similar to that in adults and no new adverse events were identified. The short term safety profiles in the different paediatric subsets were also similar (see Pharmacology: Pharmacodynamics under Actions). Adverse events seen more frequently in the paediatric population as compared to adults are: nasopharyngitis and pyrexia.
In a long-term observational paediatric study involving 115 patients, the safety profile was consistent with that reported in previous paediatric studies and no new adverse events were identified (see Pharmacology: Pharmacodynamics under Actions).
View ADR Reporting Link
Continue with Google